Michael O. Boylan

Case Western Reserve University — United States

Medicine · Health Sciences

23h-index1.8kcitations62works18.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Diabetes Treatment and Management(17), Pancreatic function and diabetes(11), bioluminescence and chemiluminescence research(10), Neuropeptides and Animal Physiology(9), Metabolism, Diabetes, and Cancer(8)

Publications62 total

Glucose-Dependent Insulinotropic Polypeptide in Incretin Physiology: Role in Health and Disease
Endocrine Reviews·2025· 18 citedOpen Access
Glucose‐dependent insulinotropic polypeptide monoclonal antibodies prevent and treat obesity in wild‐type and hyperphagic mice
Obesity·2023· 6 citedOpen Access
Mo1913 THE PREVENTION AND TREATMENT OF OBESITY IN WILD-TYPE (WT) AND HYPERPHAGIC LEPTIN-DEFICIENT (OB/OB) MICE USING MONOCLONAL ANTIBODIES (MABS) TO GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE (GIP) OCCURS INDEPENDENTLY OF APPETITE SUPPRESSION
Gastroenterology·2023
S1447 Monoclonal Antibodies (mAbs) to Glucose-Dependent Insulinotropic Polypeptide (GIP) Prevent and Treat Obesity in Wild-Type (wt) and Leptin-Deficient (ob/ob) Mice
The American Journal of Gastroenterology·2022
S1462 Generation of a High-Affinity, Humanized Monoclonal Antibody (mAb) That Effectively Neutralizes Glucose-Dependent Insulinotropic Polypeptide (GIP)
The American Journal of Gastroenterology·2022
Fatty acid transport protein-2 regulates glycemic control and diabetic kidney disease progression
JCI Insight·2020· 74 citedOpen Access
Effects of gastric inhibitory polypeptide (GIP) immunoneutralization on mouse motor coordination and memory
Peptides·2019· 1 cited
Humanization of a Gastric Inhibitory Polypeptide (GIP)-Neutralizing Monoclonal Antibody (MAB) and Weight Reversal in Diet-Induced Obese Mice
Gastroenterology·2017· 1 cited
Proceedings of the 2nd International Conference on Obesity and Chronic Diseases (ICOCD-2017)
Journal of Obesity and Chronic Diseases·2017Open Access
Su1963 A High-Affinity Humanized Monoclonal Antibody Effectively Neutralizes Gastric Inhibitory Polypeptide
Gastroenterology·2016
A novel point mutation in Prpf8 causes defects in left-right axis establishment in the mouse
Research Portal (King's College London)·2015Open Access
Gastric inhibitory polypeptide immunoneutralization attenuates development of obesity in mice
American Journal of Physiology-Endocrinology and Metabolism·2015· 64 citedOpen Access
The Drosophila Insulin Receptor Independently Modulates Lifespan and Locomotor Senescence
PLoS ONE·2015· 35 citedOpen Access
Su2066 Immunoneutralization of Gastric Inhibitory Polypeptide (GIP) Attenuates Weight Gain in Mice
Gastroenterology·2015· 1 cited
136 Attenuation of Hepatic Steatosis in Mice Using Specific Monoclonal Antibodies to Gastric Inhibitory Polypeptide (GIP)
Gastroenterology·2015
Obesity and the Gastrointestinal Tract
Journal of Clinical Gastroenterology·2014· 13 cited
Sa2058 GIP/FC-IgG Fusions With Receptor Antagonist Activity
Gastroenterology·2014
Mo1983 Engineering of Murine Embryonic Stem Cells to Express and Release Gastric Inhibitory Polypeptide (GIP)
Gastroenterology·2013Open Access
Engineering of murine embryonic stem cells to express and release gastric inhibitory polypeptide
Regulatory Peptides·2012
Engineering of Murine Embryonic Stem Cells to Express and Release Human Growth Hormone in a Murine Model
Gastroenterology·2011Open Access
page 1 of 4Next →

Frequent Co-authors

M. Michael Wolfe(26), Edward A. Meighen(11), Lisa I. Jepeal(8), Angus Graham(6), Carol M. Miyamoto(5), Patricia A. Glazebrook(4), Satish K. Singh(4), Timothy J. Kieffer(3), Linda A. Jarboe(3), Joseph A. Mancini(3), Robert R. Soly(3), Barbara E. Corkey(2), Milos Tatalovic(2), Jerry Pelletier(2), Aaron C. Bartoo(2), Selvi Krishnan(2), John H. Schwartz(2), Stefano Ferri(2), M.M. Wolfe(2), Raghav Sood(2)